300482 万孚生物
交易中 04-28 13:52:48
资讯
新帖
简况
万孚生物（300482）2025年一季报简析：净利润减13.37%，应收账款上升
证券之星 · 04-25 22:39
万孚生物（300482）2025年一季报简析：净利润减13.37%，应收账款上升
万孚生物(300482.SZ)发布一季度业绩，归母净利润1.89亿元，下降13.37%
智通财经 · 04-24
万孚生物(300482.SZ)发布一季度业绩，归母净利润1.89亿元，下降13.37%
【万孚生物等成立新公司 含集成电路设计业务】 公开资料显示，近日，广州华智康生物技术有限公司成立，法定代表人为于吉东，注册资本为100万元，经营范围包含：健康咨询服务；细胞技术研发和应用；人工智能应用软件开发；人工智能基础软件开发；集成电路设计等。股权数据显示，该公司由北京万孚智能科技有限公司全资持股，后者由万孚生物等共同持股。
金融界 · 04-22
【万孚生物等成立新公司 含集成电路设计业务】 公开资料显示，近日，广州华智康生物技术有限公司成立，法定代表人为于吉东，注册资本为100万元，经营范围包含：健康咨询服务；细胞技术研发和应用；人工智能应用软件开发；人工智能基础软件开发；集成电路设计等。股权数据显示，该公司由北京万孚智能科技有限公司全资持股，后者由万孚生物等共同持股。
基蛋输了！不准“悔婚”
市场资讯 · 03-06
基蛋输了！不准“悔婚”
万孚生物：公司始终高度重视全体股东的合理投资回报
证券之星 · 02-27
万孚生物：公司始终高度重视全体股东的合理投资回报
万孚生物（300482）2月14日主力资金净买入9928.00万元
证券之星 · 02-17
万孚生物（300482）2月14日主力资金净买入9928.00万元
2月14日万孚生物涨11.35%，汇安资产轮动混合A基金重仓该股
证券之星 · 02-14
2月14日万孚生物涨11.35%，汇安资产轮动混合A基金重仓该股
万孚生物新注册《万孚瞭望塔数据分析系统（手机端）V2.0》项目的软件著作权
证券之星 · 02-10
万孚生物新注册《万孚瞭望塔数据分析系统（手机端）V2.0》项目的软件著作权
【量价齐升榜前十：爱威科技连续5天放量上涨，累计涨幅7.49%】截至2月6日收盘，爱威科技量价齐升，连续5天放量上涨，累计涨幅7.49%。其余量价齐升的上涨个股还包括：格灵深瞳（放量上涨5天）、浙数文化（放量上涨5天）、中信出版（放量上涨5天）、严牌股份（放量上涨5天）、天地在线（放量上涨4天）、万孚生物（放量上涨4天）、交大思诺（放量上涨4天）、明月镜片（放量上涨4天）、掌阅科技（放量上涨4天）。
金融界 · 02-06
【量价齐升榜前十：爱威科技连续5天放量上涨，累计涨幅7.49%】截至2月6日收盘，爱威科技量价齐升，连续5天放量上涨，累计涨幅7.49%。其余量价齐升的上涨个股还包括：格灵深瞳（放量上涨5天）、浙数文化（放量上涨5天）、中信出版（放量上涨5天）、严牌股份（放量上涨5天）、天地在线（放量上涨4天）、万孚生物（放量上涨4天）、交大思诺（放量上涨4天）、明月镜片（放量上涨4天）、掌阅科技（放量上涨4天）。
万孚生物：拟于2025年3月28日披露2024年年度报告
金融界 · 01-27
万孚生物：拟于2025年3月28日披露2024年年度报告
万孚生物1月23日现1笔大宗交易 成交金额757.16万元
新浪证券-红岸工作室 · 01-23
万孚生物1月23日现1笔大宗交易 成交金额757.16万元
1月23日万孚生物现1笔大宗交易 机构净卖出757.16万元
证券之星 · 01-23
1月23日万孚生物现1笔大宗交易 机构净卖出757.16万元
万孚生物(300482.SZ)美国子公司呼吸道三联检产品获得美国FDA 510(k)许可
智通财经网 · 01-17
万孚生物(300482.SZ)美国子公司呼吸道三联检产品获得美国FDA 510(k)许可
1月10日万孚生物创60日新低，富国均衡策略混合基金重仓该股
证券之星 · 01-10
1月10日万孚生物创60日新低，富国均衡策略混合基金重仓该股
万孚生物1月8日现1笔大宗交易 成交金额207.21万元
新浪证券-红岸工作室 · 01-08
万孚生物1月8日现1笔大宗交易 成交金额207.21万元
1月8日万孚生物现207.21万元大宗交易
证券之星 · 01-08
1月8日万孚生物现207.21万元大宗交易
12月31日万孚生物创60日新低，富国均衡策略混合基金重仓该股
证券之星 · 2024-12-31
12月31日万孚生物创60日新低，富国均衡策略混合基金重仓该股
微策生物IPO投研报告：折戟注册关，业绩连续两年大幅下滑
时代周报-时代在线 · 2024-12-23
微策生物IPO投研报告：折戟注册关，业绩连续两年大幅下滑
12月9日万孚生物发生1笔大宗交易 成交金额219.96万元
证券之星 · 2024-12-09
12月9日万孚生物发生1笔大宗交易 成交金额219.96万元
万孚生物新注册《万孚子痫前期风险评估软件V3.33.0》项目的软件著作权
证券之星 · 2024-11-26
万孚生物新注册《万孚子痫前期风险评估软件V3.33.0》项目的软件著作权
加载更多
公司概况
公司名称：
广州万孚生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2015-06-30
主营业务：
广州万孚生物技术股份有限公司的主营业务是快速诊断试剂及配套仪器的研发、生产智造、营销及服务。公司的主要产品是传染病检测、慢性疾病检测、妊娠及优生优育检测、毒品(药物滥用)检测。公司先后荣获国家火炬计划重点高新技术企业、国家生物工程高技术产业化示范基地、国家知识产权优势企业、世界海关组织AEO高级认证企业、国家认定企业技术中心、博士后科研工作站、国家知识产权示范企业、广东省第一批制造业单项冠军企业等资质，是国内首批通过美国FDA现场审核的体外诊断试剂企业之一，并建有国家发改委批准的POCT领域唯一的国家级工程实验室。2025年1月，公司获得国家级“绿色工厂”称号。
发行价格：
16.00
{"stockData":{"symbol":"300482","market":"SZ","secType":"STK","nameCN":"万孚生物","latestPrice":20.59,"timestamp":1745819568000,"preClose":20.89,"halted":0,"volume":3648078,"delay":0,"changeRate":-0.0144,"floatShares":430000000,"shares":480999999,"eps":1.106,"marketStatus":"交易中","change":-0.3,"latestTime":"04-28 13:52:48","open":20.9,"high":20.9,"low":20.48,"amount":75010600,"amplitude":0.0201,"askPrice":20.6,"askSize":17,"bidPrice":20.59,"bidSize":75,"shortable":0,"etf":0,"ttmEps":1.106,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745823600000},"marketStatusCode":2,"adr":0,"adjPreClose":20.89,"symbolType":"stock","openAndCloseTimeList":[[1745803800000,1745811000000],[1745816400000,1745823600000]],"highLimit":22.98,"lowLimit":18.8,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":481424354,"isCdr":false,"pbRate":1.78,"roa":"--","peRate":18.616637,"roe":"3.35%","epsLYR":1.21,"committee":0.285714,"marketValue":9913000000,"turnoverRate":0.0085,"status":1,"floatMarketCap":8862000000},"requestUrl":"/m/hq/s/300482","defaultTab":"news","newsList":[{"id":"2530913991","title":"万孚生物（300482）2025年一季报简析：净利润减13.37%，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2530913991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530913991?lang=zh_cn&edition=full","pubTime":"2025-04-26 06:39","pubTimestamp":1745620775,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期万孚生物发布2025年一季报。截至本报告期末，公司营业总收入8.0亿元，同比下降7.06%，归母净利润1.89亿元，同比下降13.37%。本报告期万孚生物应收账款上升，应收账款同比增幅达83.47%。去年的净利率为18.44%，算上全部成本后，公司产品或服务的附加值高。财报体检工具显示：建议关注公司应收账款状况分析师工具显示：证券研究员普遍预期2025年业绩在6.47亿元，每股收益均值在1.34元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600007424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300482"],"gpt_icon":0},{"id":"2529671137","title":"万孚生物(300482.SZ)发布一季度业绩，归母净利润1.89亿元，下降13.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529671137","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529671137?lang=zh_cn&edition=full","pubTime":"2025-04-24 17:20","pubTimestamp":1745486417,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万孚生物(300482.SZ)发布2025年第一季度报告，该公司营业收入为8亿元，同比减少7.06%。归属于上市公司股东的净利润为1.89亿元，同比减少13.37%。归属于上市公司股东的扣除非经常性损益的净利润为1.72亿元，同比减少17.57%。基本每股收益为0.39元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300482"],"gpt_icon":0},{"id":"2529116367","title":"【万孚生物等成立新公司 含集成电路设计业务】 公开资料显示，近日，广州华智康生物技术有限公司成立，法定代表人为于吉东，注册资本为100万元，经营范围包含：健康咨询服务；细胞技术研发和应用；人工智能应用软件开发；人工智能基础软件开发；集成电路设计等。股权数据显示，该公司由北京万孚智能科技有限公司全资持股，后者由万孚生物等共同持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529116367","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529116367?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:58","pubTimestamp":1745287091,"startTime":"0","endTime":"0","summary":"公开资料显示，近日，广州华智康生物技术有限公司成立，法定代表人为于吉东，注册资本为100万元，经营范围包含：健康咨询服务；细胞技术研发和应用；人工智能应用软件开发；人工智能基础软件开发；集成电路设计等。股权数据显示，该公司由北京万孚智能科技有限公司全资持股，后者由万孚生物等共同持股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22095849737794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159546","BK0239","BK0046","161631","BK0197","300482"],"gpt_icon":0},{"id":"2517137823","title":"基蛋输了！不准“悔婚”","url":"https://stock-news.laohu8.com/highlight/detail?id=2517137823","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517137823?lang=zh_cn&edition=full","pubTime":"2025-03-06 17:34","pubTimestamp":1741253640,"startTime":"0","endTime":"0","summary":" A股又见“悔婚”大战，主角是被投资人戏称为“不孵蛋”的基蛋生物和武汉景川诊断技术股份有限公司。 2月26日晚间，基蛋生物与景川诊断的又一桩股权收购纠纷案迎来终审判决，基蛋生物最终被判支付股权收购款约3586.12万元。 如今看来，基蛋生物显然无法“悔婚”，不过基蛋生物并没有就此罢休。 值得注意的是，基蛋生物在2023年就出现了“业绩转折点”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-03-06/doc-inenthxi3440774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688298","688399","300482","BK0239","BK0046","BK0197","603387","BK0042"],"gpt_icon":0},{"id":"2514739848","title":"万孚生物：公司始终高度重视全体股东的合理投资回报","url":"https://stock-news.laohu8.com/highlight/detail?id=2514739848","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514739848?lang=zh_cn&edition=full","pubTime":"2025-02-27 12:00","pubTimestamp":1740628819,"startTime":"0","endTime":"0","summary":"证券之星消息，万孚生物02月26日在投资者关系平台上答复投资者关心的问题。公司始终高度重视全体股东的合理投资回报，积极回馈广大投资者，并兼顾公司的可持续发展。具体产品销售情况请留意公司相关公告。投资者：董秘你好，请问截止2月13日，公司的股东人数是多少万孚生物董秘：尊敬的投资者，您好！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022700017586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0239","300482","BK0046"],"gpt_icon":0},{"id":"2512961820","title":"万孚生物（300482）2月14日主力资金净买入9928.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512961820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512961820?lang=zh_cn&edition=full","pubTime":"2025-02-17 09:11","pubTimestamp":1739754688,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年2月14日收盘，万孚生物报收于24.92元，上涨11.35%，换手率7.44%，成交量31.99万手，成交额7.7亿元。近5日资金流向一览见下表：万孚生物融资融券信息显示，融资方面，当日融资买入7537.7万元，融资偿还7514.3万元，融资净买入23.4万元。万孚生物主营业务：专业从事快速诊断试剂及配套仪器的研发、制造、营销及服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021700002070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0239","BK0046","300482"],"gpt_icon":0},{"id":"2511465992","title":"2月14日万孚生物涨11.35%，汇安资产轮动混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2511465992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511465992?lang=zh_cn&edition=full","pubTime":"2025-02-14 16:24","pubTimestamp":1739521489,"startTime":"0","endTime":"0","summary":"证券之星消息，2月14日万孚生物涨11.35%，收盘报24.92元，换手率7.44%，成交量31.99万手，成交额7.7亿元。重仓万孚生物的公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为33.52。根据2024基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为汇安资产轮动混合A。汇安资产轮动混合A目前规模为0.11亿元，最新净值0.8785，较上一交易日下跌0.94%，近一年下跌10.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400025533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0197","300482","BK0046"],"gpt_icon":0},{"id":"2510933508","title":"万孚生物新注册《万孚瞭望塔数据分析系统（手机端）V2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2510933508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510933508?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:38","pubTimestamp":1739209094,"startTime":"0","endTime":"0","summary":"证券之星消息，近日万孚生物（300482）新注册了《万孚瞭望塔数据分析系统（手机端）V2.0》项目的软件著作权。今年以来万孚生物新注册软件著作权1个。结合公司2024年中报财务数据，2024上半年公司在研发方面投入了1.97亿元，同比增3.45%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021100000437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0197","300482","BK0046"],"gpt_icon":0},{"id":"2509593241","title":"【量价齐升榜前十：爱威科技连续5天放量上涨，累计涨幅7.49%】截至2月6日收盘，爱威科技量价齐升，连续5天放量上涨，累计涨幅7.49%。其余量价齐升的上涨个股还包括：格灵深瞳（放量上涨5天）、浙数文化（放量上涨5天）、中信出版（放量上涨5天）、严牌股份（放量上涨5天）、天地在线（放量上涨4天）、万孚生物（放量上涨4天）、交大思诺（放量上涨4天）、明月镜片（放量上涨4天）、掌阅科技（放量上涨4天）。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509593241","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509593241?lang=zh_cn&edition=full","pubTime":"2025-02-06 16:42","pubTimestamp":1738831339,"startTime":"0","endTime":"0","summary":"截至2月6日收盘，爱威科技量价齐升，连续5天放量上涨，累计涨幅7.49%。其余量价齐升的上涨个股还包括：格灵深瞳（放量上涨5天）、浙数文化（放量上涨5天）、中信出版（放量上涨5天）、严牌股份（放量上涨5天）、天地在线（放量上涨4天）、万孚生物（放量上涨4天）、交大思诺（放量上涨4天）、明月镜片（放量上涨4天）、掌阅科技（放量上涨4天）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/06164247986459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600633","BK0268","301081","603533","300851","BK0251","688067","BK0197","688207","300482","BK0083","BK0098","BK0217","BK0239","BK0149","301101","002995","300788","BK0028","BK0231","BK0188","BK0090","BK0046","BK0111","BK0094"],"gpt_icon":0},{"id":"2506127233","title":"万孚生物：拟于2025年3月28日披露2024年年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2506127233","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506127233?lang=zh_cn&edition=full","pubTime":"2025-01-27 11:49","pubTimestamp":1737949787,"startTime":"0","endTime":"0","summary":"金融界1月27日消息，有投资者在互动平台向万孚生物提问：公司何时出年报。公司回答表示：公司拟于2025年3月28日披露2024年年度报告。\n\n\r\n 责任编辑：栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/27114947837320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0197","300482","BK0239","BK0046"],"gpt_icon":0},{"id":"2505629130","title":"万孚生物1月23日现1笔大宗交易 成交金额757.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505629130","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505629130?lang=zh_cn&edition=full","pubTime":"2025-01-23 17:00","pubTimestamp":1737622800,"startTime":"0","endTime":"0","summary":" 1月23日，万孚生物收涨0.27%，收盘价为21.95元，发生1笔大宗交易，合计成交量34.59万股，成交金额757.16万元。 第1笔成交价格为21.89元，成交34.59万股，成交金额757.16万元，溢价率为-0.27%，买方营业部为国泰君安证券股份有限公司济南经十路证券营业部，卖方营业部为机构专用。 进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为1184.33万元。该股近5个交易日累计上涨0.05%，主力资金合计净流出1718.04万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-01-23/doc-inefyeca3613126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","300482","BK0239","BK0197"],"gpt_icon":0},{"id":"2505149069","title":"1月23日万孚生物现1笔大宗交易 机构净卖出757.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505149069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505149069?lang=zh_cn&edition=full","pubTime":"2025-01-23 16:58","pubTimestamp":1737622739,"startTime":"0","endTime":"0","summary":"证券之星消息，1月23日万孚生物发生大宗交易，交易数据如下：大宗交易成交价格21.89元，相对当日收盘价折价0.27%，成交34.59万股，成交金额757.16万元，买方营业部为国泰君安证券股份有限公司济南经十路证券营业部，卖方营业部为机构专用。近三个月该股共发生3笔大宗交易，合计成交5303.0手，折价成交1笔，溢价成交2笔。截至2025年1月23日收盘，万孚生物报收于21.95元，上涨0.27%，换手率0.76%，成交量3.27万手，成交额7223.93万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012300033078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0239","300482","BK0046"],"gpt_icon":0},{"id":"2504134365","title":"万孚生物(300482.SZ)美国子公司呼吸道三联检产品获得美国FDA 510(k)许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2504134365","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504134365?lang=zh_cn&edition=full","pubTime":"2025-01-17 17:57","pubTimestamp":1737107850,"startTime":"0","endTime":"0","summary":"万孚生物(300482.SZ)公告，公司美国全资子公司Wondfo USA Co....","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/2.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/2.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1239489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300482","BK0046","BK0197","BK0239"],"gpt_icon":0},{"id":"2502839336","title":"1月10日万孚生物创60日新低，富国均衡策略混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2502839336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502839336?lang=zh_cn&edition=full","pubTime":"2025-01-10 16:30","pubTimestamp":1736497857,"startTime":"0","endTime":"0","summary":"证券之星消息，1月10日万孚生物创60日新低，收盘报21.33元，当日跌2.07%，换手率0.88%，成交量3.79万手，成交额8188.1万元。重仓万孚生物的公募基金请见下表：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家；过去90天内机构目标均价为33.76。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为富国均衡策略混合。该公募基金现任基金经理为蒲世林。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011000026568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","300482","BK0239"],"gpt_icon":0},{"id":"2501532743","title":"万孚生物1月8日现1笔大宗交易 成交金额207.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501532743","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501532743?lang=zh_cn&edition=full","pubTime":"2025-01-08 17:00","pubTimestamp":1736326800,"startTime":"0","endTime":"0","summary":" 1月8日，万孚生物收跌0.82%，收盘价为21.88元，发生1笔大宗交易，合计成交量9.44万股，成交金额207.21万元。 进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为427.17万元。该股近5个交易日累计下跌2.37%，主力资金合计净流出2925.65万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-01-08/doc-ineefzcz4032162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0197","BK0239","300482","BK0046"],"gpt_icon":0},{"id":"2501874866","title":"1月8日万孚生物现207.21万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2501874866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501874866?lang=zh_cn&edition=full","pubTime":"2025-01-08 16:53","pubTimestamp":1736326427,"startTime":"0","endTime":"0","summary":"证券之星消息，1月8日万孚生物发生大宗交易，交易数据如下：大宗交易成交价格21.95元，相对当日收盘价溢价0.32%，成交9.44万股，成交金额207.21万元，买方营业部为中信证券股份有限公司北京安外大街证券营业部，卖方营业部为中信建投证券股份有限公司重庆青枫北路证券营业部。近三个月该股共发生2笔大宗交易，合计成交1844.0手，溢价成交2笔。截至2025年1月8日收盘，万孚生物报收于21.88元，下跌0.82%，换手率1.09%，成交量4.69万手，成交额1.02亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010800028367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0197","300482"],"gpt_icon":0},{"id":"2495663807","title":"12月31日万孚生物创60日新低，富国均衡策略混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2495663807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495663807?lang=zh_cn&edition=full","pubTime":"2024-12-31 16:26","pubTimestamp":1735633590,"startTime":"0","endTime":"0","summary":"证券之星消息，12月31日万孚生物创60日新低，收盘报22.41元，当日跌2.27%，换手率1.59%，成交量5.27万手，成交额1.19亿元。重仓万孚生物的公募基金请见下表：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家；过去90天内机构目标均价为33.76。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为富国均衡策略混合。该公募基金现任基金经理为蒲世林。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123100027225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0197","300482","BK0046"],"gpt_icon":0},{"id":"2493757533","title":"微策生物IPO投研报告：折戟注册关，业绩连续两年大幅下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2493757533","media":"时代周报-时代在线","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493757533?lang=zh_cn&edition=full","pubTime":"2024-12-23 20:00","pubTimestamp":1734955200,"startTime":"0","endTime":"0","summary":"在新冠疫情期间，微策生物凭借新冠检测产品迅速崛起，然而，随着新冠疫情影响的逐步消退和市场需求减少，该公司的业绩下滑明显。然而，自2022年起，微策生物的业绩连续两年大幅下滑，2023年归母净利润或不足4000万元。今年6月9日，深交所官网显示，微策生物撤回材料，终止创业板IPO。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-23/doc-ineancvm2461708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","600030","BK0239","LU0405327494.USD","LU2495084118.USD","300298","LU1064130708.USD","LU1997244956.HKD","BK0028","LU1064131003.USD","BK0046","BK0251","LU0405327148.USD","688075","LU1997245094.SGD","LU1997245177.USD","BK0197","BK0196","LU2148510915.USD","300482","LU2289578879.USD","BK0114","LU1328615791.USD","688298","BK0183","BK0276","688606","BK0012","BK0102"],"gpt_icon":0},{"id":"2490984743","title":"12月9日万孚生物发生1笔大宗交易 成交金额219.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490984743","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490984743?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:45","pubTimestamp":1733733958,"startTime":"0","endTime":"0","summary":"证券之星消息，12月9日万孚生物发生大宗交易，交易数据如下：大宗交易成交价格24.44元，相对当日收盘价溢价0.33%，成交9万股，成交金额219.96万元，买方营业部为国泰君安证券股份有限公司重庆中山三路证券营业部，卖方营业部为中信建投证券股份有限公司北京东城分公司。近三个月该股共发生2笔大宗交易，合计成交2076.0手，溢价成交1笔。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900021158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300482","BK0197","BK0046"],"gpt_icon":0},{"id":"2486889432","title":"万孚生物新注册《万孚子痫前期风险评估软件V3.33.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2486889432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486889432?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:11","pubTimestamp":1732641074,"startTime":"0","endTime":"0","summary":"证券之星消息，近日万孚生物（300482）新注册了《万孚子痫前期风险评估软件V3.33.0》项目的软件著作权。今年以来万孚生物新注册软件著作权3个，较去年同期减少了0%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了1.97亿元，同比增3.45%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700000907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","300482","BK0239","BK0046"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1745819571448,"stockEarnings":[{"period":"1week","weight":0.0092},{"period":"1month","weight":-0.105},{"period":"3month","weight":-0.0556},{"period":"6month","weight":-0.1928},{"period":"1year","weight":-0.2101},{"period":"ytd","weight":-0.0678}],"compareEarnings":[{"period":"1week","weight":0.0056},{"period":"1month","weight":-0.0219},{"period":"3month","weight":0.013},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.0793},{"period":"ytd","weight":-0.0169}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州万孚生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42296人(较上一季度增加2.33%)","perCapita":"10175股","listingDate":"2015-06-30","address":"广东省广州市黄埔区科学城荔枝山路8号","registeredCapital":"48142万元","survey":" 广州万孚生物技术股份有限公司的主营业务是快速诊断试剂及配套仪器的研发、生产智造、营销及服务。公司的主要产品是传染病检测、慢性疾病检测、妊娠及优生优育检测、毒品(药物滥用)检测。公司先后荣获国家火炬计划重点高新技术企业、国家生物工程高技术产业化示范基地、国家知识产权优势企业、世界海关组织AEO高级认证企业、国家认定企业技术中心、博士后科研工作站、国家知识产权示范企业、广东省第一批制造业单项冠军企业等资质，是国内首批通过美国FDA现场审核的体外诊断试剂企业之一，并建有国家发改委批准的POCT领域唯一的国家级工程实验室。2025年1月，公司获得国家级“绿色工厂”称号。","listedPrice":16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万孚生物(300482)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万孚生物(300482)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万孚生物,300482,万孚生物股票,万孚生物股票老虎,万孚生物股票老虎国际,万孚生物行情,万孚生物股票行情,万孚生物股价,万孚生物股市,万孚生物股票价格,万孚生物股票交易,万孚生物股票购买,万孚生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万孚生物(300482)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万孚生物(300482)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}